EMVision Medical Devices Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMV.AX research report →
Price Chart
About the company
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
- CEO
- Scott Philip Kirkland
- IPO
- 2018
- Employees
- 46
- HQ
- Macquarie Park, NSW, AU
Get TickerSpark's AI analysis on EMV.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $168.22M
- P/E
- -15.40
- PEG
- 0.28
- P/S
- 107.61
- P/B
- 8.17
- EV/EBITDA
- -11.91
- Div Yield
- 0.00%
- Gross Margin
- 86.26%
- Op Margin
- -825.16%
- Net Margin
- -652.61%
- ROE
- -70.29%
- ROIC
- -47.47%
Latest fiscal year · YoY change
- Revenue
- $5.05M-55.0%
- Gross Profit
- $5.05M-55.0%
- Op Income
- $-8,128,859
- Net Income
- $-9,805,536-259.2%
- EPS
- $-0.11-224.5%
- OCF Growth
- -30.8%
- FCF Growth
- -25.3%
- 52W High
- $2.43
- 52W Low
- $1.47
- 50D MA
- $1.60
- 200D MA
- $1.71
- Beta
- 1.05
- RSI (14)
- 63
- Avg Volume
- 39.88K
No earnings-call transcripts are available for EMV.AX yet.
- Free Float
- 66.0%
- Shares Outstanding
- 92.94M
- Float Shares
- 61.34M
Our EMV.AX coverage
Recent articles, reports, and earnings notes.
No research on EMV.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EMV.AX report →